PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
GHM vs. LLY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between GHM and LLY is 0.10, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

GHM vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Graham Corporation (GHM) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

0.00%20.00%40.00%60.00%SeptemberOctoberNovemberDecember2025February
68.46%
7.31%
GHM
LLY

Key characteristics

Sharpe Ratio

GHM:

2.90

LLY:

0.82

Sortino Ratio

GHM:

3.64

LLY:

1.32

Omega Ratio

GHM:

1.45

LLY:

1.17

Calmar Ratio

GHM:

2.58

LLY:

1.07

Martin Ratio

GHM:

14.70

LLY:

2.51

Ulcer Index

GHM:

9.76%

LLY:

10.34%

Daily Std Dev

GHM:

49.58%

LLY:

31.51%

Max Drawdown

GHM:

-86.10%

LLY:

-68.27%

Current Drawdown

GHM:

-0.76%

LLY:

-13.81%

Fundamentals

Market Cap

GHM:

$510.74M

LLY:

$742.90B

EPS

GHM:

$0.70

LLY:

$9.32

PE Ratio

GHM:

67.00

LLY:

88.63

PEG Ratio

GHM:

0.77

LLY:

0.77

Total Revenue (TTM)

GHM:

$152.58M

LLY:

$31.51B

Gross Profit (TTM)

GHM:

$36.99M

LLY:

$25.63B

EBITDA (TTM)

GHM:

$13.19M

LLY:

$9.48B

Returns By Period

In the year-to-date period, GHM achieves a 5.46% return, which is significantly lower than LLY's 7.00% return. Over the past 10 years, GHM has underperformed LLY with an annualized return of 8.93%, while LLY has yielded a comparatively higher 30.48% annualized return.


GHM

YTD

5.46%

1M

-0.76%

6M

61.61%

1Y

113.57%

5Y*

22.36%

10Y*

8.93%

LLY

YTD

7.00%

1M

5.64%

6M

4.46%

1Y

17.74%

5Y*

43.22%

10Y*

30.48%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

GHM vs. LLY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GHM
The Risk-Adjusted Performance Rank of GHM is 9595
Overall Rank
The Sharpe Ratio Rank of GHM is 9797
Sharpe Ratio Rank
The Sortino Ratio Rank of GHM is 9595
Sortino Ratio Rank
The Omega Ratio Rank of GHM is 9393
Omega Ratio Rank
The Calmar Ratio Rank of GHM is 9393
Calmar Ratio Rank
The Martin Ratio Rank of GHM is 9595
Martin Ratio Rank

LLY
The Risk-Adjusted Performance Rank of LLY is 7171
Overall Rank
The Sharpe Ratio Rank of LLY is 7474
Sharpe Ratio Rank
The Sortino Ratio Rank of LLY is 6767
Sortino Ratio Rank
The Omega Ratio Rank of LLY is 6666
Omega Ratio Rank
The Calmar Ratio Rank of LLY is 8080
Calmar Ratio Rank
The Martin Ratio Rank of LLY is 7070
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

GHM vs. LLY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Graham Corporation (GHM) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for GHM, currently valued at 2.90, compared to the broader market-2.000.002.004.002.900.82
The chart of Sortino ratio for GHM, currently valued at 3.64, compared to the broader market-4.00-2.000.002.004.003.641.32
The chart of Omega ratio for GHM, currently valued at 1.45, compared to the broader market0.501.001.502.001.451.17
The chart of Calmar ratio for GHM, currently valued at 2.58, compared to the broader market0.002.004.006.002.581.07
The chart of Martin ratio for GHM, currently valued at 14.70, compared to the broader market-10.000.0010.0020.0030.0014.702.51
GHM
LLY

The current GHM Sharpe Ratio is 2.90, which is higher than the LLY Sharpe Ratio of 0.82. The chart below compares the historical Sharpe Ratios of GHM and LLY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.501.001.502.002.503.00SeptemberOctoberNovemberDecember2025February
2.90
0.82
GHM
LLY

Dividends

GHM vs. LLY - Dividend Comparison

GHM has not paid dividends to shareholders, while LLY's dividend yield for the trailing twelve months is around 0.63%.


TTM20242023202220212020201920182017201620152014
GHM
Graham Corporation
0.00%0.00%0.00%0.00%3.54%2.90%1.92%1.66%1.72%1.63%1.90%0.56%
LLY
Eli Lilly and Company
0.63%0.67%0.78%1.07%1.23%1.75%1.96%1.95%2.46%2.77%2.37%2.84%

Drawdowns

GHM vs. LLY - Drawdown Comparison

The maximum GHM drawdown since its inception was -86.10%, which is greater than LLY's maximum drawdown of -68.27%. Use the drawdown chart below to compare losses from any high point for GHM and LLY. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-0.76%
-13.81%
GHM
LLY

Volatility

GHM vs. LLY - Volatility Comparison

Graham Corporation (GHM) has a higher volatility of 15.11% compared to Eli Lilly and Company (LLY) at 10.91%. This indicates that GHM's price experiences larger fluctuations and is considered to be riskier than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%SeptemberOctoberNovemberDecember2025February
15.11%
10.91%
GHM
LLY

Financials

GHM vs. LLY - Financials Comparison

This section allows you to compare key financial metrics between Graham Corporation and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab